Long-term results for patients with unresectable gastric cancer who received chemotherapy in the Japan Clinical Oncology Group (JCOG) trials

Gastric Cancer

Volumn 3, Issue 3, 2000, Pages 145-150

  Ohkuwa, Masana ^a,b   Ohtsu, Atsushi ^a   Boku, Narikazu ^a   Yoshida, Shigeaki ^a   Miyata, Yoshinori ^c   Shirao, Kuniaki ^d   Shimada, Yasuhiro ^d   Kurihara, Minoru ^e  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e SHOWA UNIVERSITY KOTO TOYOSU HOSPITAL   (Japan)

Author keywords

Chemotherapy; Gastric cancer; Long term survival

Indexed keywords

CISPLATIN; DOXIFLURIDINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C; TEGAFUR; UFT;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL TRIAL; FEMALE; HUMAN; INOPERABLE CANCER; JAPAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PARAAORTIC LYMPH NODE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0034484032     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011709     Document Type: Article

References (14)

1. Modified therapy with 5-fluorouracil doxorubicin, and methotrexaic in advanced gastric cancer
2. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer
3. Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus best supportive care with best supportive care alone in patients with non-resectable gastric cancer
4. Pallialive chemotherapy versus supportive care in patients with metastatic gastric cancer: A randomized trial
5. A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer
6. A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci
7. A phase II study of EAP (etoposide, adriamycin and cisplatin) in the patients with advanced gastric cancer: Multi-institutional study
8. Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG)
9. Nonparametric estimation for incomplete observations
10. A long-surviving case of gastric cancer with liver metastasis without signs of recurrence for 6 years after palliative operation
11. A case report of long-term survival in advanced gastric cancer with multiple liver metastases treated with mitomycin C and tegafur therapy after palliative gastrectomy
12. A natural history of advanced gastric cancer
13. The natural history of gastric cancer and prognostic factors influencing survival